Merck Q2 net profit jumps over 2-fold to ₹ 48 crore
The company had posted a net profit of ₹ 20.12 crore for the corresponding period of the previous fiscal
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Glenmark’s partner Elite Pharmaceuticals receives US FDA approval
The company received approval for abbreviated new drug application for methadone hydrochloride 5 mg and 10 mg tablets
Grundfos Forum 2018 to broadcast from Suzhou, China
The virtual conference will broadcast live on August 15 and 16, 2018 and OnDemand from August 17 to October 14, 2018
Dr Cyrus Poonawalla felicitated by Sharad Pawar
Dr Poonawalla was recently bestowed with the honorary degree by the University of Massachusetts in the US earlier this year for…
Cipla receives final approval for generic Voltaren Gel
The non-steroidal anti-inflammatory drug is indicated for the relief of the pain of osteoarthritis of joints amenable to topical…
Sun Pharma launches novel drug Kapspargo Sprinkle in US
First US FDA approved, extended-release sprinkle formulation of metoprolol succinate indicated for treatment of patients with…
Merck’s Accelerator programme opens for application
The programme will take place from mid-January until April 2019 at the Merck Innovation Center in Darmstadt, Germany
Sanofi launches multiple sclerosis tab in India
Aubagio offers patients diagnosed with multiple sclerosis the efficacy and convenience of once-a-day oral treatment
Glenmark Pharmaceuticals, Harbour BioMed in agreement
To develop GBR 1302, a first-in-class bispecific antibody for treatment of HER2-Positive cancers in Greater China territory
Intas Pharmaceuticals to be first to launch Pegfilgrastim biosimilar in Europe
Pelgraz, a pegylated G-CSF Biosimilar, is the latest addition to its established portfolio of over 30 oncology treatments across…